Factors affecting successful breast conservation for ductal carcinoma in situ
- PMID: 17443388
- DOI: 10.1245/s10434-006-9246-y
Factors affecting successful breast conservation for ductal carcinoma in situ
Abstract
Background: Successful breast-conserving therapy in DCIS is restricted by high rates of residual disease resulting in the need for radiotherapy and/or re-excision. This study identifies patients with DCIS who are most at risk of compromised margins and of residual disease.
Methods: All patients undergoing breast-conserving surgery for DCIS over a 6-year period were included. Method of diagnosis, mammographic size, pathological size, DCIS-margin distance and residual disease on re-excision were analysed.
Results: One hundred and thirty-five patients underwent initial breast-conserving surgery for DCIS. The compromised margin rate was 72%, and the rate of residual disease on re-operation was 54%. On univariate analysis, underestimation of pathological size by mammography by >1 cm occurred in 40% of those with compromised margins undergoing a therapeutic operation compared to only 14% of those with clear margins (P = 0.02). However, on multivariate analysis only pathological size (P < 0.0001, OR = 1.0,95% CI 1.037-1.128) and lack of a preoperative diagnosis by core biopsy (P < 0.0001, OR = 5.3,95% CI 1.859-15.08) were predictive of compromised margins. The presence of residual disease on re-excision was associated with increasing pathological size (P < 0.0001, OR = 1.085,95% CI 1.038-1.134) and decreasing DCIS-margin distance (P = 0.03, OR = 6.694,95% CI 1.84-37.855). Twenty-nine percent (n = 13/45) of lesions < or =3 cm compared to 84% (n = 27/32) of lesions >3 cm had residual disease on re-operation (P < 0.0001). Residual disease was present in 62% (n = 34/55), 64% (n = 7/11) and 17% (n = 2/12) of patients with DCIS-margin distances < or =1, 1-2 and 2-5 mm, respectively.
Conclusion: Considerable underestimation of DCIS extent by mammography occurs in a high proportion of patients with compromised margins in breast conservation. Patients at particularly high risk of residual disease on re-excision are those with lesions >3 cm and those with DCIS-margin distances of < or = 2mm.
Similar articles
-
Predictors of surgical margin status in breast-conserving surgery within a breast screening program.Ann Surg Oncol. 2008 Sep;15(9):2542-9. doi: 10.1245/s10434-008-0054-4. Epub 2008 Jul 10. Ann Surg Oncol. 2008. PMID: 18618180
-
Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.Ann Surg Oncol. 2009 Nov;16(11):3020-7. doi: 10.1245/s10434-009-0628-9. Epub 2009 Jul 28. Ann Surg Oncol. 2009. PMID: 19636632
-
Margin index is not a reliable tool for predicting residual disease after breast-conserving surgery for DCIS.Ann Surg Oncol. 2011 Oct;18(11):3155-9. doi: 10.1245/s10434-011-1918-6. Epub 2011 Sep 27. Ann Surg Oncol. 2011. PMID: 21947593
-
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9. Breast Cancer Res Treat. 2008. PMID: 17687650 Review.
-
[The treatment of ductal carcinoma in situ (DCIS) of the breast].Ned Tijdschr Geneeskd. 2003 Nov 1;147(44):2157-61. Ned Tijdschr Geneeskd. 2003. PMID: 14626831 Review. Dutch.
Cited by
-
Imaging-assisted large-format breast pathology: program rationale and development in a nonprofit health system in the United States.Int J Breast Cancer. 2012;2012:171792. doi: 10.1155/2012/171792. Epub 2012 Dec 17. Int J Breast Cancer. 2012. PMID: 23316372 Free PMC article.
-
Radiopathological features predictive of involved margins in ductal carcinoma in situ.Ann R Coll Surg Engl. 2017 Feb;99(2):137-144. doi: 10.1308/rcsann.2016.0299. Epub 2016 Sep 23. Ann R Coll Surg Engl. 2017. PMID: 27659365 Free PMC article.
-
Optimization of a widefield structured illumination microscope for non-destructive assessment and quantification of nuclear features in tumor margins of a primary mouse model of sarcoma.PLoS One. 2013 Jul 23;8(7):e68868. doi: 10.1371/journal.pone.0068868. Print 2013. PLoS One. 2013. PMID: 23894357 Free PMC article.
-
Predictors of Reexcision following Breast-Conserving Surgery for Ductal Carcinoma In Situ.Ann Surg Oncol. 2021 Mar;28(3):1390-1397. doi: 10.1245/s10434-020-09101-5. Epub 2020 Sep 10. Ann Surg Oncol. 2021. PMID: 32914389
-
Advances in Breast MRI in the Setting of Ductal Carcinoma In Situ.Semin Roentgenol. 2018 Oct;53(4):261-269. doi: 10.1053/j.ro.2018.08.006. Epub 2018 Aug 30. Semin Roentgenol. 2018. PMID: 30449344 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical